PER 0.00% 13.5¢ percheron therapeutics limited

Ann: PIIb DMD trial approved in Bulgaria- UK, Australia advancing, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 367 Posts.
    lightbulb Created with Sketch. 137
    Hopefully this ANN will remind folks that we do in fact have a catalyst rich few months ahead of us.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.